A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults
Condition(s):Epstein-Barr Virus InfectionLast Updated:November 21, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Epstein-Barr Virus InfectionLast Updated:November 21, 2023Active, not recruiting
Condition(s):Epstein-Barr Virus InfectionsLast Updated:July 2, 2017Completed
Condition(s):Epstein-Barr Virus InfectionLast Updated:February 1, 2024Active, not recruiting
Condition(s):Epstein-Barr Virus Infections; ImmunodeficiencyLast Updated:February 9, 2023Completed
Condition(s):Epstein-Barr Virus InfectionsLast Updated:April 13, 2015Completed
Condition(s):Epstein Barr Virus Infection; HealthyLast Updated:July 2, 2017Completed
Condition(s):Epstein-Barr Virus InfectionsLast Updated:January 18, 2020Completed
Condition(s):Fatigue Syndrome, Chronic; Epstein-Barr Virus InfectionsLast Updated:June 28, 2017Completed
Condition(s):Epstein-Barr Virus InfectionsLast Updated:January 29, 2015Completed
Condition(s):EBV InfectionLast Updated:October 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.